Outcomes

Based on available literature, omega-3 EPA/DHA supplementation shows measurable effects across several health domains, though evidence strength varies significantly by condition.

Cardiovascular and Inflammatory Markers

Studies report improvements in atherosclerotic plaque burden, composition, and stability with omega-3 supplementation, though specific quantitative measures are not detailed in the available evidence. One pooled analysis of four supplementation trials found an inverse association between omega-3 index levels and neutrophil-lymphocyte ratio, suggesting anti-inflammatory effects. However, the clinical significance of these biomarker changes requires further clarification.

Metabolic Outcomes

Limited evidence suggests omega-3 supplementation may affect liver function biomarkers and glucose metabolism in type 2 diabetes, based on completed clinical trials. However, specific outcome measures and effect sizes are not reported in the available evidence.

Pediatric ADHD

A systematic review and meta-analysis examined omega-3 supplementation in pediatric ADHD using biomarker stratification approaches. While this suggests measurable outcomes in attention and behavioral symptoms, the specific results and magnitude of effects are not detailed in the available evidence.

Sarcopenia and Muscle Function

One triple-blind randomized controlled trial investigated omega-3 supplementation effects on sarcopenia following bariatric surgery. The study design suggests measurement of muscle-related outcomes, but specific results are not provided in the available evidence.

Reproductive Health

Research indicates omega-3 fatty acids may influence biomarkers related to infertility and recurrent spontaneous abortion, though the direction and clinical significance of these changes are not specified in the available evidence.

Evidence Limitations

The available evidence provides limited specific outcome data, effect sizes, or confidence intervals for most reported studies. Many investigations appear to be ongoing or recently completed, with detailed results not yet published. The strength of evidence varies considerably across different health conditions, with some areas having only preliminary or pilot study data.

Note: This summary is based on limited available evidence and should not be used for personal medical decisions. Consult healthcare providers for individualized advice regarding omega-3 supplementation.

Omega-3 EPA/DHA

Member access required